The use of benzodiazepines and the mental health of women in prison : a cross‑sectional study

Detalhes bibliográficos
Autor(a) principal: Einloft, Fernanda Miranda Seixas
Data de Publicação: 2023
Outros Autores: Kopittke, Luciane, Dias, Míriam Thaís Guterres, Schultz, Águida Luana Veriato, Dotta-Panichi, Renata Maria, Barros, Helena Maria Tannhauser
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/262532
Resumo: In this article we assessed the prevalence of benzodiazepine (BZD) use in women before and during imprisonment, as well as its related factors and association with symptoms of anxiety, depression, and posttraumatic stress disorder in a quantitative, cross-sectional, analytical study of regional scope. Two female prisons in the Brazilian Prison System were included. Seventy-four women participated by completing questionnaires about their sociodemographic data, BZD use and use of other substances. These questionnaires included the Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), and Posttraumatic Stress Disorder Checklist–Civilian Version (PCL-C). Of the 46 women who reported no BZDs use before arrest, 29 (63%) began using BZDs during imprisonment (p < 0.001). Positive scores for PTSD, anxiety, and depression, as well as associations between BZD use during imprisonment and anxiety (p= 0.028), depression (p = 0.001) and comorbid anxiety and depression (p= 0.003) were found when a bivariate Poisson regression was performed. When a multivariate Poisson regression was performed for tobacco use, the PHQ-9 and GAD-7 scales, BZD use was associated with depression (p= p = 0.008), with tobacco use (p = 0.012), but not with anxiety (p = 0.325). Imprisonment increases the psychological sufering of women, consequently increasing BZD use. Nonpharmacological measures need to be considered in the health care of incarcerated women.
id UFRGS-2_9545f862435fef91708b474ed962544f
oai_identifier_str oai:www.lume.ufrgs.br:10183/262532
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Einloft, Fernanda Miranda SeixasKopittke, LucianeDias, Míriam Thaís GuterresSchultz, Águida Luana VeriatoDotta-Panichi, Renata MariaBarros, Helena Maria Tannhauser2023-07-21T03:30:42Z20232045-2322http://hdl.handle.net/10183/262532001170696In this article we assessed the prevalence of benzodiazepine (BZD) use in women before and during imprisonment, as well as its related factors and association with symptoms of anxiety, depression, and posttraumatic stress disorder in a quantitative, cross-sectional, analytical study of regional scope. Two female prisons in the Brazilian Prison System were included. Seventy-four women participated by completing questionnaires about their sociodemographic data, BZD use and use of other substances. These questionnaires included the Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), and Posttraumatic Stress Disorder Checklist–Civilian Version (PCL-C). Of the 46 women who reported no BZDs use before arrest, 29 (63%) began using BZDs during imprisonment (p < 0.001). Positive scores for PTSD, anxiety, and depression, as well as associations between BZD use during imprisonment and anxiety (p= 0.028), depression (p = 0.001) and comorbid anxiety and depression (p= 0.003) were found when a bivariate Poisson regression was performed. When a multivariate Poisson regression was performed for tobacco use, the PHQ-9 and GAD-7 scales, BZD use was associated with depression (p= p = 0.008), with tobacco use (p = 0.012), but not with anxiety (p = 0.325). Imprisonment increases the psychological sufering of women, consequently increasing BZD use. Nonpharmacological measures need to be considered in the health care of incarcerated women.application/pdfengScientific reports. London. Vol. 13 (2023), 4491, p. 1-9MulheresPrisõesBenzodiazepinasSaúde mentalThe use of benzodiazepines and the mental health of women in prison : a cross‑sectional studyEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001170696.pdf.txt001170696.pdf.txtExtracted Texttext/plain43437http://www.lume.ufrgs.br/bitstream/10183/262532/2/001170696.pdf.txt55533e6492d04db2cb6d9265f8798129MD52ORIGINAL001170696.pdfTexto completo (inglês)application/pdf1250264http://www.lume.ufrgs.br/bitstream/10183/262532/1/001170696.pdf745ba5a07c9e2d895ad3c66d1547c498MD5110183/2625322023-07-22 03:41:24.505379oai:www.lume.ufrgs.br:10183/262532Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2023-07-22T06:41:24Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv The use of benzodiazepines and the mental health of women in prison : a cross‑sectional study
title The use of benzodiazepines and the mental health of women in prison : a cross‑sectional study
spellingShingle The use of benzodiazepines and the mental health of women in prison : a cross‑sectional study
Einloft, Fernanda Miranda Seixas
Mulheres
Prisões
Benzodiazepinas
Saúde mental
title_short The use of benzodiazepines and the mental health of women in prison : a cross‑sectional study
title_full The use of benzodiazepines and the mental health of women in prison : a cross‑sectional study
title_fullStr The use of benzodiazepines and the mental health of women in prison : a cross‑sectional study
title_full_unstemmed The use of benzodiazepines and the mental health of women in prison : a cross‑sectional study
title_sort The use of benzodiazepines and the mental health of women in prison : a cross‑sectional study
author Einloft, Fernanda Miranda Seixas
author_facet Einloft, Fernanda Miranda Seixas
Kopittke, Luciane
Dias, Míriam Thaís Guterres
Schultz, Águida Luana Veriato
Dotta-Panichi, Renata Maria
Barros, Helena Maria Tannhauser
author_role author
author2 Kopittke, Luciane
Dias, Míriam Thaís Guterres
Schultz, Águida Luana Veriato
Dotta-Panichi, Renata Maria
Barros, Helena Maria Tannhauser
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Einloft, Fernanda Miranda Seixas
Kopittke, Luciane
Dias, Míriam Thaís Guterres
Schultz, Águida Luana Veriato
Dotta-Panichi, Renata Maria
Barros, Helena Maria Tannhauser
dc.subject.por.fl_str_mv Mulheres
Prisões
Benzodiazepinas
Saúde mental
topic Mulheres
Prisões
Benzodiazepinas
Saúde mental
description In this article we assessed the prevalence of benzodiazepine (BZD) use in women before and during imprisonment, as well as its related factors and association with symptoms of anxiety, depression, and posttraumatic stress disorder in a quantitative, cross-sectional, analytical study of regional scope. Two female prisons in the Brazilian Prison System were included. Seventy-four women participated by completing questionnaires about their sociodemographic data, BZD use and use of other substances. These questionnaires included the Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), and Posttraumatic Stress Disorder Checklist–Civilian Version (PCL-C). Of the 46 women who reported no BZDs use before arrest, 29 (63%) began using BZDs during imprisonment (p < 0.001). Positive scores for PTSD, anxiety, and depression, as well as associations between BZD use during imprisonment and anxiety (p= 0.028), depression (p = 0.001) and comorbid anxiety and depression (p= 0.003) were found when a bivariate Poisson regression was performed. When a multivariate Poisson regression was performed for tobacco use, the PHQ-9 and GAD-7 scales, BZD use was associated with depression (p= p = 0.008), with tobacco use (p = 0.012), but not with anxiety (p = 0.325). Imprisonment increases the psychological sufering of women, consequently increasing BZD use. Nonpharmacological measures need to be considered in the health care of incarcerated women.
publishDate 2023
dc.date.accessioned.fl_str_mv 2023-07-21T03:30:42Z
dc.date.issued.fl_str_mv 2023
dc.type.driver.fl_str_mv Estrangeiro
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/262532
dc.identifier.issn.pt_BR.fl_str_mv 2045-2322
dc.identifier.nrb.pt_BR.fl_str_mv 001170696
identifier_str_mv 2045-2322
001170696
url http://hdl.handle.net/10183/262532
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Scientific reports. London. Vol. 13 (2023), 4491, p. 1-9
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/262532/2/001170696.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/262532/1/001170696.pdf
bitstream.checksum.fl_str_mv 55533e6492d04db2cb6d9265f8798129
745ba5a07c9e2d895ad3c66d1547c498
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1815447832716378112